01 Procurement
Tender overview
- Buyer
- NHS England
- Status
- Complete
- Procurement method
- Open procedure
- Category
- goods
- CPV classification
- Not supplied
- Tender period
- Not supplied — 30 October 2025
Description
Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.
02 Awards and contracts
Published award records
Lot 1 - CM/TNS/25/5734
- Awarded
- 26 November 2025
- Award value
- £87,433,000
- Suppliers
- 3
- Signed contract
- Not supplied
NHS National Framework Agreement for Omalizumab
- Awarded
- Not supplied
- Award value
- Not supplied
- Suppliers
- 3
- Signed contract
- 12 December 2025
03 Organisations
Buyers, suppliers and other parties
NHS England
Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
GB-PPON PDPT-3135-BWWYCelltrion Healthcare United Kingdom Limited
The Charter Building, Uxbridge, UKI74, UB8 1JG, United Kingdom
Companies House 11685363 →MERCURY PHARMACEUTICALS LIMITED
Dashwood House, London, UKI31, EC2M 1QS, United Kingdom
Companies House 02619880 →NOVARTIS PHARMACEUTICALS UK LIMITED
2nd Floor, The Westworks Building White City Place, London, UKI33, W12 7FQ, United Kingdom
Companies House 00119006 →Companies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.
04 Provenance
Source for this process
Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.